These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6444359)

  • 1. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets.
    Ochs HD; Slichter SJ; Harker LA; Von Behrens WE; Clark RA; Wedgwood RJ
    Blood; 1980 Feb; 55(2):243-52. PubMed ID: 6444359
    [No Abstract]   [Full Text] [Related]  

  • 2. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
    Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
    J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Some immunohematological aspects of 2 cases of the Wiskott-Aldrich syndrome].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(1):75-80. PubMed ID: 6604260
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome.
    Meuwissen HJ; Bortin MM; Bach FH; Porter IH; Schreinmachers D; Harrison BA; Taft E
    J Pediatr; 1984 Sep; 105(3):365-9. PubMed ID: 6381679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome.
    Higgins EA; Siminovitch KA; Zhuang DL; Brockhausen I; Dennis JW
    J Biol Chem; 1991 Apr; 266(10):6280-90. PubMed ID: 2007580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic applications of thymostimulin (TP-1) in two cases of Wiskott-Aldrich's syndrome].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(1):59-63. PubMed ID: 6604259
    [No Abstract]   [Full Text] [Related]  

  • 7. Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.
    Lau YL; Jones BM; Low LC; Wong SN; Leung NK
    Eur J Pediatr; 1992 Sep; 151(9):680-3. PubMed ID: 1396930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.
    Jyonouchi S; Gwafila B; Gwalani LA; Ahmad M; Moertel C; Holbert C; Kim JY; Kobrinsky N; Roy-Ghanta S; Orange JS
    Clin Immunol; 2017 Jun; 179():47-53. PubMed ID: 28232030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome.
    de Martino M; Galli L; Azzari C; Zammarchi E; Vierucci A
    Vox Sang; 1994; 67(3):317-9. PubMed ID: 7863634
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in Wiskott-Aldrich syndrome: case report and literature review.
    Cheng DS; Cosgriff TM; Kitahara M
    Am J Med Sci; 1981; 282(2):85-90. PubMed ID: 7325190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
    Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
    J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature of the platelet defect in the Wiskott-Aldrich syndrome.
    Baldini MG
    Ann N Y Acad Sci; 1972 Oct; 201():437-44. PubMed ID: 4265132
    [No Abstract]   [Full Text] [Related]  

  • 14. X-linked thrombocytopenia and thrombocytopathia: attenuated Wiskott-Aldrich syndrome. Functional and morphological studies of platelets and lymphocytes.
    Stormorken H; Hellum B; Egeland T; Abrahamsen TG; Hovig T
    Thromb Haemost; 1991 Mar; 65(3):300-5. PubMed ID: 2048054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prenatal study of fetal platelet count and size with application to fetus at risk for Wiskott-Aldrich syndrome.
    Holmberg L; Gustavii B; Jönsson A
    J Pediatr; 1983 May; 102(5):773-6. PubMed ID: 6842338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.
    Zabay JM; Fontán G; Campos A; García-Rodriguez MC; Pascual-Salcedo D; Bootello A; de la Concha EG
    Clin Exp Immunol; 1984 Apr; 56(1):23-8. PubMed ID: 6609033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome.
    Parkman R; Remold-O'Donnell E; Kenney DM; Perrine S; Rosen FS
    Lancet; 1981 Dec 19-26; 2(8260-61):1387-9. PubMed ID: 6118760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persistent thrombocytopenia in a child: morphological examination of blood platelets established the diagnosis of Wiskott-Aldrich syndrome].
    Latger-Cannard V; Lacroix F; Devignes J; Salignac S; Bensoussan D; Salmon A; Mansuy L; Bordigoni P; Lecompte T
    Ann Biol Clin (Paris); 2008; 66(1):100-4. PubMed ID: 18227012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.